IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,140 | +2.8% | 14,685 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -28.6% | 14,685 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | 0.0% | 14,685 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | -12.5% | 14,685 | 0.0% | 0.00% | – |
Q4 2021 | $8,000 | -46.7% | 14,685 | 0.0% | 0.00% | – |
Q3 2021 | $15,000 | -16.7% | 14,685 | 0.0% | 0.00% | – |
Q2 2021 | $18,000 | -5.3% | 14,685 | 0.0% | 0.00% | – |
Q1 2021 | $19,000 | -69.4% | 14,685 | -12.6% | 0.00% | – |
Q4 2020 | $62,000 | +72.2% | 16,797 | 0.0% | 0.00% | – |
Q3 2020 | $36,000 | +20.0% | 16,797 | 0.0% | 0.00% | – |
Q2 2020 | $30,000 | +36.4% | 16,797 | -0.0% | 0.00% | – |
Q1 2020 | $22,000 | -29.0% | 16,798 | +0.0% | 0.00% | – |
Q4 2019 | $31,000 | -82.1% | 16,797 | -72.0% | 0.00% | – |
Q3 2019 | $173,000 | +45.4% | 60,010 | +35.1% | 0.00% | – |
Q2 2019 | $119,000 | -17.9% | 44,409 | -22.4% | 0.00% | – |
Q1 2019 | $145,000 | -9.4% | 57,204 | -0.9% | 0.00% | – |
Q4 2018 | $160,000 | -69.3% | 57,704 | -1.5% | 0.00% | – |
Q3 2018 | $521,000 | – | 58,557 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |